CA Stock MarketDetailed Quotes

FRX Fennec Pharmaceuticals Inc

Watchlist
  • 8.490
  • 0.0000.00%
15min DelayMarket Closed Nov 29 16:00 ET
232.90MMarket Cap-157222P/E (TTM)

Fennec Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
7.05%6.97M
118.41%7.26M
1,413.24%25.38M
1,284.50%21.25M
534.20%9.74M
6.52M
3.33M
1.68M
1.54M
1.54M
Operating revenue
15.42%7.99M
155.08%9.47M
1,413.24%25.38M
1,284.50%21.25M
468.53%8.73M
--6.92M
--3.71M
--1.68M
--1.54M
--1.54M
Cost of revenue
309.97%1.36M
310.81%608K
478.95%550K
1,363.95%1.26M
696.51%685K
331K
148K
95K
86K
86K
Gross profit
-9.17%5.62M
109.44%6.65M
1,469.34%24.83M
1,279.78%19.99M
524.57%9.05M
6.18M
3.18M
1.58M
1.45M
1.45M
Operating expense
49.04%10.84M
49.09%11.69M
60.37%11.1M
36.65%33.05M
42.91%10.94M
-8.67%7.27M
56.58%7.84M
94.88%6.92M
40.43%24.19M
81.93%7.65M
Selling and administrative expenses
49.14%10.72M
47.24%11.54M
61.81%11.08M
59.50%32.71M
45.12%10.84M
1.93%7.19M
102.04%7.84M
224.70%6.85M
67.51%20.51M
102.69%7.47M
-Selling and marketing expense
35.96%4.6M
99.66%4.67M
105.81%5.21M
335.30%12.12M
38.89%3.87M
--3.38M
--2.34M
--2.53M
--2.79M
--2.79M
-General and administrative expense
60.87%6.12M
24.91%6.86M
36.02%5.87M
16.16%20.59M
48.83%6.97M
-46.05%3.81M
41.70%5.5M
104.69%4.32M
44.76%17.72M
27.09%4.68M
Research and development costs
708.33%97K
1,862.50%157K
-25.00%3K
-98.41%56K
-72.65%32K
-98.58%12K
-99.29%8K
-99.72%4K
-29.11%3.53M
-77.63%117K
Depreciation amortization depletion
-70.83%21K
----
-72.22%20K
92.62%287K
0.00%70K
12.50%72K
----
928.57%72K
--149K
--70K
-Depreciation and amortization
-70.83%21K
----
-72.22%20K
92.62%287K
0.00%70K
12.50%72K
----
928.57%72K
--149K
--70K
Operating profit
-379.61%-5.22M
-7.99%-5.04M
356.89%13.72M
42.57%-13.06M
69.57%-1.89M
86.32%-1.09M
6.85%-4.67M
-50.35%-5.34M
-32.02%-22.74M
-47.49%-6.21M
Net non-operating interest income (expenses)
32.49%-509K
36.53%-497K
-21.48%-837K
-277.14%-2.95M
-35.36%-800K
-693.68%-754K
-1,298.21%-783K
-1,306.12%-689K
-789.77%-783K
-936.84%-591K
Non-operating interest income
405.88%516K
395.65%570K
80.73%197K
126.15%441K
-24.84%115K
325.00%102K
1,177.78%115K
1,111.11%109K
261.11%195K
1,076.92%153K
Non-operating interest expense
19.74%1.03M
26.55%1.04M
29.57%1.03M
247.03%3.39M
22.98%915K
619.33%856K
1,347.37%825K
1,275.86%798K
676.19%978K
1,100.00%744K
Total other finance cost
----
-68.49%23K
----
----
----
----
812.50%73K
----
----
----
Other net income (expenses)
87.50%-3K
-440.00%-17K
-133.33%-49K
82.38%-34K
109.84%6K
22.58%-24K
171.43%5K
77.66%-21K
-451.43%-193K
62.58%-61K
Gain on sale of security
87.50%-3K
-440.00%-17K
-133.33%-49K
82.38%-34K
109.84%6K
22.58%-24K
171.43%5K
77.66%-21K
-451.43%-193K
62.58%-61K
Income before tax
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
32.34%-16.05M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-36.71%-23.71M
-54.89%-6.86M
Income tax
Earnings from equity interest net of tax
Net income
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
32.34%-16.05M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-36.71%-23.71M
-54.89%-6.86M
Net income continuous operations
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
32.34%-16.05M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-36.71%-23.71M
-54.89%-6.86M
Noncontrolling interests
Net income attributable to the company
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
32.34%-16.05M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-36.71%-23.71M
-54.89%-6.86M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
32.34%-16.05M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-36.71%-23.71M
-54.89%-6.86M
Diluted earnings per share
-200.00%-0.21
4.76%-0.2
304.35%0.47
33.33%-0.6
60.00%-0.1
77.42%-0.07
-10.53%-0.21
-64.29%-0.23
-34.33%-0.9
-47.06%-0.25
Basic earnings per share
-200.00%-0.21
4.76%-0.2
278.26%0.41
33.33%-0.6
60.00%-0.1
77.42%-0.07
-10.53%-0.21
-64.29%-0.23
-34.33%-0.9
-47.06%-0.25
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 7.05%6.97M118.41%7.26M1,413.24%25.38M1,284.50%21.25M534.20%9.74M6.52M3.33M1.68M1.54M1.54M
Operating revenue 15.42%7.99M155.08%9.47M1,413.24%25.38M1,284.50%21.25M468.53%8.73M--6.92M--3.71M--1.68M--1.54M--1.54M
Cost of revenue 309.97%1.36M310.81%608K478.95%550K1,363.95%1.26M696.51%685K331K148K95K86K86K
Gross profit -9.17%5.62M109.44%6.65M1,469.34%24.83M1,279.78%19.99M524.57%9.05M6.18M3.18M1.58M1.45M1.45M
Operating expense 49.04%10.84M49.09%11.69M60.37%11.1M36.65%33.05M42.91%10.94M-8.67%7.27M56.58%7.84M94.88%6.92M40.43%24.19M81.93%7.65M
Selling and administrative expenses 49.14%10.72M47.24%11.54M61.81%11.08M59.50%32.71M45.12%10.84M1.93%7.19M102.04%7.84M224.70%6.85M67.51%20.51M102.69%7.47M
-Selling and marketing expense 35.96%4.6M99.66%4.67M105.81%5.21M335.30%12.12M38.89%3.87M--3.38M--2.34M--2.53M--2.79M--2.79M
-General and administrative expense 60.87%6.12M24.91%6.86M36.02%5.87M16.16%20.59M48.83%6.97M-46.05%3.81M41.70%5.5M104.69%4.32M44.76%17.72M27.09%4.68M
Research and development costs 708.33%97K1,862.50%157K-25.00%3K-98.41%56K-72.65%32K-98.58%12K-99.29%8K-99.72%4K-29.11%3.53M-77.63%117K
Depreciation amortization depletion -70.83%21K-----72.22%20K92.62%287K0.00%70K12.50%72K----928.57%72K--149K--70K
-Depreciation and amortization -70.83%21K-----72.22%20K92.62%287K0.00%70K12.50%72K----928.57%72K--149K--70K
Operating profit -379.61%-5.22M-7.99%-5.04M356.89%13.72M42.57%-13.06M69.57%-1.89M86.32%-1.09M6.85%-4.67M-50.35%-5.34M-32.02%-22.74M-47.49%-6.21M
Net non-operating interest income (expenses) 32.49%-509K36.53%-497K-21.48%-837K-277.14%-2.95M-35.36%-800K-693.68%-754K-1,298.21%-783K-1,306.12%-689K-789.77%-783K-936.84%-591K
Non-operating interest income 405.88%516K395.65%570K80.73%197K126.15%441K-24.84%115K325.00%102K1,177.78%115K1,111.11%109K261.11%195K1,076.92%153K
Non-operating interest expense 19.74%1.03M26.55%1.04M29.57%1.03M247.03%3.39M22.98%915K619.33%856K1,347.37%825K1,275.86%798K676.19%978K1,100.00%744K
Total other finance cost -----68.49%23K----------------812.50%73K------------
Other net income (expenses) 87.50%-3K-440.00%-17K-133.33%-49K82.38%-34K109.84%6K22.58%-24K171.43%5K77.66%-21K-451.43%-193K62.58%-61K
Gain on sale of security 87.50%-3K-440.00%-17K-133.33%-49K82.38%-34K109.84%6K22.58%-24K171.43%5K77.66%-21K-451.43%-193K62.58%-61K
Income before tax -207.18%-5.74M-2.00%-5.55M312.11%12.84M32.34%-16.05M60.89%-2.68M76.92%-1.87M-7.33%-5.44M-63.74%-6.05M-36.71%-23.71M-54.89%-6.86M
Income tax
Earnings from equity interest net of tax
Net income -207.18%-5.74M-2.00%-5.55M312.11%12.84M32.34%-16.05M60.89%-2.68M76.92%-1.87M-7.33%-5.44M-63.74%-6.05M-36.71%-23.71M-54.89%-6.86M
Net income continuous operations -207.18%-5.74M-2.00%-5.55M312.11%12.84M32.34%-16.05M60.89%-2.68M76.92%-1.87M-7.33%-5.44M-63.74%-6.05M-36.71%-23.71M-54.89%-6.86M
Noncontrolling interests
Net income attributable to the company -207.18%-5.74M-2.00%-5.55M312.11%12.84M32.34%-16.05M60.89%-2.68M76.92%-1.87M-7.33%-5.44M-63.74%-6.05M-36.71%-23.71M-54.89%-6.86M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -207.18%-5.74M-2.00%-5.55M312.11%12.84M32.34%-16.05M60.89%-2.68M76.92%-1.87M-7.33%-5.44M-63.74%-6.05M-36.71%-23.71M-54.89%-6.86M
Diluted earnings per share -200.00%-0.214.76%-0.2304.35%0.4733.33%-0.660.00%-0.177.42%-0.07-10.53%-0.21-64.29%-0.23-34.33%-0.9-47.06%-0.25
Basic earnings per share -200.00%-0.214.76%-0.2278.26%0.4133.33%-0.660.00%-0.177.42%-0.07-10.53%-0.21-64.29%-0.23-34.33%-0.9-47.06%-0.25
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data